Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
作者
Axel Hauschild,Paolo A. Ascierto,Dirk Schadendorf,Jean‐Jacques Grob,Antoni Ribas,Felix Kiecker,Caroline Dutriaux,Лев Вадимович Демидов,Célèste Lebbé,Piotr Lukasz Rutkowski,Christian U. Blank,Ralf Gutzmer,Michael J. Millward,Richard F. Kefford,Tomas Haas,Anthony Michael D'amelio,Eduard Gasal,Bijoyesh Mookerjee,Paul B. Chapman